FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


141007 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
Cytarabine 100mg/mL injection solution 10mL vial Ambiguous
Cytarabine 100mg/mL injection solution 1mL vial Ambiguous
Cytarabine 100mg/mL injection solution 20mL vial Ambiguous
Cytarabine 100mg/mL injection solution 5mL vial Ambiguous
Cytarabine 10mg/mL suspension Ambiguous
Cytarabine 1g injection (pdr for recon)+diluent A component that is no longer current, useful, appropriate or acceptable.
Cytarabine 1g powder for injection solution vial A component that is no longer current, useful, appropriate or acceptable.
Cytarabine 1g/vial injection A component that fails to comply with the current editorial guidance.
Cytarabine 1g/vial powder for injection A component that fails to comply with the current editorial guidance.
Cytarabine 20mg/mL injection solution 25mL vial Ambiguous
Cytarabine 20mg/mL injection solution 5mL A component that fails to comply with the current editorial guidance.
Cytarabine 2g/vial injection A component that fails to comply with the current editorial guidance.
Cytarabine 2g/vial powder for injection A component that fails to comply with the current editorial guidance.
Cytarabine 500mg injection (pdr for recon)+diluent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytarabine 500mg/vial injection A component that fails to comply with the current editorial guidance.
Cytarabine 500mg/vial powder for injection A component that fails to comply with the current editorial guidance.
Cytarabine liposomal 50mg/5mL injection 5mL vial A component that fails to comply with the current editorial guidance.
Cytarabine overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytarabine poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytochrome C oxidase deficiency A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytochrome P450 family 2 subfamily D member 6 extensive metabolizer A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytochrome b>3< deficiency Ambiguous
Cytochrome p450 CYP2C19 enzyme deficiency Ambiguous
Cytochrome p450 CYP2C9 enzyme deficiency A component that is no longer current, useful, appropriate or acceptable.
Cytochrome p450 CYP2D6 enzyme deficiency A component that is no longer current, useful, appropriate or acceptable.
Cytochrome-c oxidase A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytologist A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytology - general A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytology laboratory test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytology laboratory test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytology laboratory test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytology of organ NOC Classification derived component
Cytology of organ NOC NOS Classification derived component
Cytology scraper, reusable Ambiguous
Cytology scraper, single-use Ambiguous
Cytomegalic inclusion disease associated with acquired immunodeficiency syndrome Ambiguous
Cytomegalic inclusion virus hepatitis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegaloviral colitis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegaloviral encephalitis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegaloviral mononucleosis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegaloviral pancreatitis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus Ambiguous
Cytomegalovirus IgG antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus IgG antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus IgM antibody assay A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus IgM antibody assay A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus IgM level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus IgM level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus antigen test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus antigen test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus antigen test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus early antigen level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus early antigen level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus early antigen level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus group virus Ambiguous
Cytomegalovirus latex test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus latex test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus nucleic acid detection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus nucleic acid detection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus nucleic acid detection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytomegalovirus pneumonia A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytopathology procedure or service A component that fails to comply with the current editorial guidance.
Cytopathology, review of slides and report, nongenital source, by physician Ambiguous
Cytophaga species Ambiguous
Cytophaga uliginosa A component that is no longer current, useful, appropriate or acceptable.
Cytophilic antibody A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytoplasmic ANCA Screen A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytoplasmic ANCA Screen A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytoplasmic CD3 antigen A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytoplasmic CD79 antigen A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytoplasmic IgM level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytoplasmic IgM level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytoprotective agent A component that fails to comply with the current editorial guidance.
Cytoprotective agent A component that fails to comply with the current editorial guidance.
Cytostatic agent A component that fails to comply with the current editorial guidance.
Cytostatic drugs A component that fails to comply with the current editorial guidance.
Cytotec 200mcg tablet Moved elsewhere
Cytotoxic agent A component that fails to comply with the current editorial guidance.
Cytotoxic agent A component that fails to comply with the current editorial guidance.
Cytotoxic antibiotic poisoning A component that fails to comply with the current editorial guidance.
Cytotoxic antibiotics Ambiguous
Cytotoxic drug therapy NOS Classification derived component
Cytotoxic drug therapy NOS Classification derived component
Cytotoxic given orally Ambiguous
Cytotoxic given orally Ambiguous
Cytotoxic immunosuppressants Ambiguous
Cytotoxic injection NOS Classification derived component
Cytotoxic injection NOS Classification derived component
Cytotoxic material spill kit A component that fails to comply with the current editorial guidance.
Cytotoxic subarachnoid injection A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytotoxic superficial application A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytotoxin A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytotropic antibody A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cytotropic antibody level A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Czech A component that fails to comply with the current editorial guidance.
Czech Coldblood horse breed Moved elsewhere
Czech Improved White pig breed Moved elsewhere
Czech Meat pig breed Moved elsewhere
Czech Miniature pig breed Moved elsewhere
Czech Pied cattle breed Moved elsewhere
Czech Roma A component that fails to comply with the current editorial guidance.

Start Previous Page 322 of 1411 Next End


Reference Sets

Reference set descriptor

Back to Start